ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pancreatic Beta-Cell Protection Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-33D5946
Home | Market Reports | Health| Health Conditions| Cancer
Global Pancreatic Beta Cell Protection Market Insights and Forecast to 2028
BUY CHAPTERS

Global Pancreatic Beta-Cell Protection Market Research Report 2025

Code: QYRE-Auto-33D5946
Report
September 2025
Pages:84
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
ViaCyte Inc
PharmaCyte Biotech
Boehringer Ingelheim
GalaxoSmithKline
Beta-Cell NV
Novartis
Janssen Research & Development
Pfizer Inc
BioLineRx Ltd
Genentech Inc
Novo Nordisk
Sanofi
Osiris Therapeutics
Beta-O2 Technologies Ltd
Transition Therapeutics
Janssen Research & Development

Pancreatic Beta-Cell Protection Market

The global market for Pancreatic Beta-Cell Protection was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Beta Cells. Beta cells are unique cells in the pancreas that produce, store and release the hormone insulin.
North American market for Pancreatic Beta-Cell Protection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Pancreatic Beta-Cell Protection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Pancreatic Beta-Cell Protection in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Pancreatic Beta-Cell Protection include ViaCyte, PharmaCyte Biotech, Boehringer Ingelheim, GalaxoSmithKline, Beta-Cell NV, Novartis, Janssen Research & Development, Pfizer Inc, BioLineRx, Genentech, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Pancreatic Beta-Cell Protection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pancreatic Beta-Cell Protection.
The Pancreatic Beta-Cell Protection market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pancreatic Beta-Cell Protection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pancreatic Beta-Cell Protection companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Pancreatic Beta-Cell Protection Market Report

Report Metric Details
Report Name Pancreatic Beta-Cell Protection Market
Segment by Type
  • Stem Cell Based
  • Gene Therapies
  • RNA Based Therapies
  • Monoclonal Antibodies (MAbs)
  • Phytotherapy
Segment by Application
  • Hospital
  • Medical Research Laboratory
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company ViaCyte, PharmaCyte Biotech, Boehringer Ingelheim, GalaxoSmithKline, Beta-Cell NV, Novartis, Janssen Research & Development, Pfizer Inc, BioLineRx, Genentech, Novo Nordisk, Sanofi, Osiris Therapeutics, Beta-O2 Technologies Ltd, Transition Therapeutics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Pancreatic Beta-Cell Protection company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Pancreatic Beta-Cell Protection Market report?

Ans: The main players in the Pancreatic Beta-Cell Protection Market are ViaCyte, PharmaCyte Biotech, Boehringer Ingelheim, GalaxoSmithKline, Beta-Cell NV, Novartis, Janssen Research & Development, Pfizer Inc, BioLineRx, Genentech, Novo Nordisk, Sanofi, Osiris Therapeutics, Beta-O2 Technologies Ltd, Transition Therapeutics

What are the Application segmentation covered in the Pancreatic Beta-Cell Protection Market report?

Ans: The Applications covered in the Pancreatic Beta-Cell Protection Market report are Hospital, Medical Research Laboratory, Others

What are the Type segmentation covered in the Pancreatic Beta-Cell Protection Market report?

Ans: The Types covered in the Pancreatic Beta-Cell Protection Market report are Stem Cell Based, Gene Therapies, RNA Based Therapies, Monoclonal Antibodies (MAbs), Phytotherapy

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pancreatic Beta-Cell Protection Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Stem Cell Based
1.2.3 Gene Therapies
1.2.4 RNA Based Therapies
1.2.5 Monoclonal Antibodies (MAbs)
1.2.6 Phytotherapy
1.3 Market by Application
1.3.1 Global Pancreatic Beta-Cell Protection Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Medical Research Laboratory
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pancreatic Beta-Cell Protection Market Perspective (2020-2031)
2.2 Global Pancreatic Beta-Cell Protection Growth Trends by Region
2.2.1 Global Pancreatic Beta-Cell Protection Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Pancreatic Beta-Cell Protection Historic Market Size by Region (2020-2025)
2.2.3 Pancreatic Beta-Cell Protection Forecasted Market Size by Region (2026-2031)
2.3 Pancreatic Beta-Cell Protection Market Dynamics
2.3.1 Pancreatic Beta-Cell Protection Industry Trends
2.3.2 Pancreatic Beta-Cell Protection Market Drivers
2.3.3 Pancreatic Beta-Cell Protection Market Challenges
2.3.4 Pancreatic Beta-Cell Protection Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pancreatic Beta-Cell Protection Players by Revenue
3.1.1 Global Top Pancreatic Beta-Cell Protection Players by Revenue (2020-2025)
3.1.2 Global Pancreatic Beta-Cell Protection Revenue Market Share by Players (2020-2025)
3.2 Global Pancreatic Beta-Cell Protection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Pancreatic Beta-Cell Protection Revenue
3.4 Global Pancreatic Beta-Cell Protection Market Concentration Ratio
3.4.1 Global Pancreatic Beta-Cell Protection Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pancreatic Beta-Cell Protection Revenue in 2024
3.5 Global Key Players of Pancreatic Beta-Cell Protection Head office and Area Served
3.6 Global Key Players of Pancreatic Beta-Cell Protection, Product and Application
3.7 Global Key Players of Pancreatic Beta-Cell Protection, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pancreatic Beta-Cell Protection Breakdown Data by Type
4.1 Global Pancreatic Beta-Cell Protection Historic Market Size by Type (2020-2025)
4.2 Global Pancreatic Beta-Cell Protection Forecasted Market Size by Type (2026-2031)
5 Pancreatic Beta-Cell Protection Breakdown Data by Application
5.1 Global Pancreatic Beta-Cell Protection Historic Market Size by Application (2020-2025)
5.2 Global Pancreatic Beta-Cell Protection Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Pancreatic Beta-Cell Protection Market Size (2020-2031)
6.2 North America Pancreatic Beta-Cell Protection Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Pancreatic Beta-Cell Protection Market Size by Country (2020-2025)
6.4 North America Pancreatic Beta-Cell Protection Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pancreatic Beta-Cell Protection Market Size (2020-2031)
7.2 Europe Pancreatic Beta-Cell Protection Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Pancreatic Beta-Cell Protection Market Size by Country (2020-2025)
7.4 Europe Pancreatic Beta-Cell Protection Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pancreatic Beta-Cell Protection Market Size (2020-2031)
8.2 Asia-Pacific Pancreatic Beta-Cell Protection Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Region (2020-2025)
8.4 Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pancreatic Beta-Cell Protection Market Size (2020-2031)
9.2 Latin America Pancreatic Beta-Cell Protection Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Pancreatic Beta-Cell Protection Market Size by Country (2020-2025)
9.4 Latin America Pancreatic Beta-Cell Protection Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pancreatic Beta-Cell Protection Market Size (2020-2031)
10.2 Middle East & Africa Pancreatic Beta-Cell Protection Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Country (2020-2025)
10.4 Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ViaCyte
11.1.1 ViaCyte Company Details
11.1.2 ViaCyte Business Overview
11.1.3 ViaCyte Pancreatic Beta-Cell Protection Introduction
11.1.4 ViaCyte Revenue in Pancreatic Beta-Cell Protection Business (2020-2025)
11.1.5 ViaCyte Recent Development
11.2 PharmaCyte Biotech
11.2.1 PharmaCyte Biotech Company Details
11.2.2 PharmaCyte Biotech Business Overview
11.2.3 PharmaCyte Biotech Pancreatic Beta-Cell Protection Introduction
11.2.4 PharmaCyte Biotech Revenue in Pancreatic Beta-Cell Protection Business (2020-2025)
11.2.5 PharmaCyte Biotech Recent Development
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Details
11.3.2 Boehringer Ingelheim Business Overview
11.3.3 Boehringer Ingelheim Pancreatic Beta-Cell Protection Introduction
11.3.4 Boehringer Ingelheim Revenue in Pancreatic Beta-Cell Protection Business (2020-2025)
11.3.5 Boehringer Ingelheim Recent Development
11.4 GalaxoSmithKline
11.4.1 GalaxoSmithKline Company Details
11.4.2 GalaxoSmithKline Business Overview
11.4.3 GalaxoSmithKline Pancreatic Beta-Cell Protection Introduction
11.4.4 GalaxoSmithKline Revenue in Pancreatic Beta-Cell Protection Business (2020-2025)
11.4.5 GalaxoSmithKline Recent Development
11.5 Beta-Cell NV
11.5.1 Beta-Cell NV Company Details
11.5.2 Beta-Cell NV Business Overview
11.5.3 Beta-Cell NV Pancreatic Beta-Cell Protection Introduction
11.5.4 Beta-Cell NV Revenue in Pancreatic Beta-Cell Protection Business (2020-2025)
11.5.5 Beta-Cell NV Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Pancreatic Beta-Cell Protection Introduction
11.6.4 Novartis Revenue in Pancreatic Beta-Cell Protection Business (2020-2025)
11.6.5 Novartis Recent Development
11.7 Janssen Research & Development
11.7.1 Janssen Research & Development Company Details
11.7.2 Janssen Research & Development Business Overview
11.7.3 Janssen Research & Development Pancreatic Beta-Cell Protection Introduction
11.7.4 Janssen Research & Development Revenue in Pancreatic Beta-Cell Protection Business (2020-2025)
11.7.5 Janssen Research & Development Recent Development
11.8 Pfizer Inc
11.8.1 Pfizer Inc Company Details
11.8.2 Pfizer Inc Business Overview
11.8.3 Pfizer Inc Pancreatic Beta-Cell Protection Introduction
11.8.4 Pfizer Inc Revenue in Pancreatic Beta-Cell Protection Business (2020-2025)
11.8.5 Pfizer Inc Recent Development
11.9 BioLineRx
11.9.1 BioLineRx Company Details
11.9.2 BioLineRx Business Overview
11.9.3 BioLineRx Pancreatic Beta-Cell Protection Introduction
11.9.4 BioLineRx Revenue in Pancreatic Beta-Cell Protection Business (2020-2025)
11.9.5 BioLineRx Recent Development
11.10 Genentech
11.10.1 Genentech Company Details
11.10.2 Genentech Business Overview
11.10.3 Genentech Pancreatic Beta-Cell Protection Introduction
11.10.4 Genentech Revenue in Pancreatic Beta-Cell Protection Business (2020-2025)
11.10.5 Genentech Recent Development
11.11 Novo Nordisk
11.11.1 Novo Nordisk Company Details
11.11.2 Novo Nordisk Business Overview
11.11.3 Novo Nordisk Pancreatic Beta-Cell Protection Introduction
11.11.4 Novo Nordisk Revenue in Pancreatic Beta-Cell Protection Business (2020-2025)
11.11.5 Novo Nordisk Recent Development
11.12 Sanofi
11.12.1 Sanofi Company Details
11.12.2 Sanofi Business Overview
11.12.3 Sanofi Pancreatic Beta-Cell Protection Introduction
11.12.4 Sanofi Revenue in Pancreatic Beta-Cell Protection Business (2020-2025)
11.12.5 Sanofi Recent Development
11.13 Osiris Therapeutics
11.13.1 Osiris Therapeutics Company Details
11.13.2 Osiris Therapeutics Business Overview
11.13.3 Osiris Therapeutics Pancreatic Beta-Cell Protection Introduction
11.13.4 Osiris Therapeutics Revenue in Pancreatic Beta-Cell Protection Business (2020-2025)
11.13.5 Osiris Therapeutics Recent Development
11.14 Beta-O2 Technologies Ltd
11.14.1 Beta-O2 Technologies Ltd Company Details
11.14.2 Beta-O2 Technologies Ltd Business Overview
11.14.3 Beta-O2 Technologies Ltd Pancreatic Beta-Cell Protection Introduction
11.14.4 Beta-O2 Technologies Ltd Revenue in Pancreatic Beta-Cell Protection Business (2020-2025)
11.14.5 Beta-O2 Technologies Ltd Recent Development
11.15 Transition Therapeutics
11.15.1 Transition Therapeutics Company Details
11.15.2 Transition Therapeutics Business Overview
11.15.3 Transition Therapeutics Pancreatic Beta-Cell Protection Introduction
11.15.4 Transition Therapeutics Revenue in Pancreatic Beta-Cell Protection Business (2020-2025)
11.15.5 Transition Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
ViaCyte Inc
PharmaCyte Biotech
Boehringer Ingelheim
GalaxoSmithKline
Beta-Cell NV
Novartis
Janssen Research & Development
Pfizer Inc
BioLineRx Ltd
Genentech Inc
Novo Nordisk
Sanofi
Osiris Therapeutics
Beta-O2 Technologies Ltd
Transition Therapeutics
Janssen Research & Development
List of Tables
 Table 1. Global Pancreatic Beta-Cell Protection Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Stem Cell Based
 Table 3. Key Players of Gene Therapies
 Table 4. Key Players of RNA Based Therapies
 Table 5. Key Players of Monoclonal Antibodies (MAbs)
 Table 6. Key Players of Phytotherapy
 Table 7. Global Pancreatic Beta-Cell Protection Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Pancreatic Beta-Cell Protection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Pancreatic Beta-Cell Protection Market Size by Region (2020-2025) & (US$ Million)
 Table 10. Global Pancreatic Beta-Cell Protection Market Share by Region (2020-2025)
 Table 11. Global Pancreatic Beta-Cell Protection Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 12. Global Pancreatic Beta-Cell Protection Market Share by Region (2026-2031)
 Table 13. Pancreatic Beta-Cell Protection Market Trends
 Table 14. Pancreatic Beta-Cell Protection Market Drivers
 Table 15. Pancreatic Beta-Cell Protection Market Challenges
 Table 16. Pancreatic Beta-Cell Protection Market Restraints
 Table 17. Global Pancreatic Beta-Cell Protection Revenue by Players (2020-2025) & (US$ Million)
 Table 18. Global Pancreatic Beta-Cell Protection Market Share by Players (2020-2025)
 Table 19. Global Top Pancreatic Beta-Cell Protection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pancreatic Beta-Cell Protection as of 2024)
 Table 20. Ranking of Global Top Pancreatic Beta-Cell Protection Companies by Revenue (US$ Million) in 2024
 Table 21. Global 5 Largest Players Market Share by Pancreatic Beta-Cell Protection Revenue (CR5 and HHI) & (2020-2025)
 Table 22. Global Key Players of Pancreatic Beta-Cell Protection, Headquarters and Area Served
 Table 23. Global Key Players of Pancreatic Beta-Cell Protection, Product and Application
 Table 24. Global Key Players of Pancreatic Beta-Cell Protection, Date of Enter into This Industry
 Table 25. Mergers & Acquisitions, Expansion Plans
 Table 26. Global Pancreatic Beta-Cell Protection Market Size by Type (2020-2025) & (US$ Million)
 Table 27. Global Pancreatic Beta-Cell Protection Revenue Market Share by Type (2020-2025)
 Table 28. Global Pancreatic Beta-Cell Protection Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 29. Global Pancreatic Beta-Cell Protection Revenue Market Share by Type (2026-2031)
 Table 30. Global Pancreatic Beta-Cell Protection Market Size by Application (2020-2025) & (US$ Million)
 Table 31. Global Pancreatic Beta-Cell Protection Revenue Market Share by Application (2020-2025)
 Table 32. Global Pancreatic Beta-Cell Protection Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 33. Global Pancreatic Beta-Cell Protection Revenue Market Share by Application (2026-2031)
 Table 34. North America Pancreatic Beta-Cell Protection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. North America Pancreatic Beta-Cell Protection Market Size by Country (2020-2025) & (US$ Million)
 Table 36. North America Pancreatic Beta-Cell Protection Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Europe Pancreatic Beta-Cell Protection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Europe Pancreatic Beta-Cell Protection Market Size by Country (2020-2025) & (US$ Million)
 Table 39. Europe Pancreatic Beta-Cell Protection Market Size by Country (2026-2031) & (US$ Million)
 Table 40. Asia-Pacific Pancreatic Beta-Cell Protection Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Region (2020-2025) & (US$ Million)
 Table 42. Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Region (2026-2031) & (US$ Million)
 Table 43. Latin America Pancreatic Beta-Cell Protection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Latin America Pancreatic Beta-Cell Protection Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Latin America Pancreatic Beta-Cell Protection Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Middle East & Africa Pancreatic Beta-Cell Protection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 47. Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Country (2020-2025) & (US$ Million)
 Table 48. Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Country (2026-2031) & (US$ Million)
 Table 49. ViaCyte Company Details
 Table 50. ViaCyte Business Overview
 Table 51. ViaCyte Pancreatic Beta-Cell Protection Product
 Table 52. ViaCyte Revenue in Pancreatic Beta-Cell Protection Business (2020-2025) & (US$ Million)
 Table 53. ViaCyte Recent Development
 Table 54. PharmaCyte Biotech Company Details
 Table 55. PharmaCyte Biotech Business Overview
 Table 56. PharmaCyte Biotech Pancreatic Beta-Cell Protection Product
 Table 57. PharmaCyte Biotech Revenue in Pancreatic Beta-Cell Protection Business (2020-2025) & (US$ Million)
 Table 58. PharmaCyte Biotech Recent Development
 Table 59. Boehringer Ingelheim Company Details
 Table 60. Boehringer Ingelheim Business Overview
 Table 61. Boehringer Ingelheim Pancreatic Beta-Cell Protection Product
 Table 62. Boehringer Ingelheim Revenue in Pancreatic Beta-Cell Protection Business (2020-2025) & (US$ Million)
 Table 63. Boehringer Ingelheim Recent Development
 Table 64. GalaxoSmithKline Company Details
 Table 65. GalaxoSmithKline Business Overview
 Table 66. GalaxoSmithKline Pancreatic Beta-Cell Protection Product
 Table 67. GalaxoSmithKline Revenue in Pancreatic Beta-Cell Protection Business (2020-2025) & (US$ Million)
 Table 68. GalaxoSmithKline Recent Development
 Table 69. Beta-Cell NV Company Details
 Table 70. Beta-Cell NV Business Overview
 Table 71. Beta-Cell NV Pancreatic Beta-Cell Protection Product
 Table 72. Beta-Cell NV Revenue in Pancreatic Beta-Cell Protection Business (2020-2025) & (US$ Million)
 Table 73. Beta-Cell NV Recent Development
 Table 74. Novartis Company Details
 Table 75. Novartis Business Overview
 Table 76. Novartis Pancreatic Beta-Cell Protection Product
 Table 77. Novartis Revenue in Pancreatic Beta-Cell Protection Business (2020-2025) & (US$ Million)
 Table 78. Novartis Recent Development
 Table 79. Janssen Research & Development Company Details
 Table 80. Janssen Research & Development Business Overview
 Table 81. Janssen Research & Development Pancreatic Beta-Cell Protection Product
 Table 82. Janssen Research & Development Revenue in Pancreatic Beta-Cell Protection Business (2020-2025) & (US$ Million)
 Table 83. Janssen Research & Development Recent Development
 Table 84. Pfizer Inc Company Details
 Table 85. Pfizer Inc Business Overview
 Table 86. Pfizer Inc Pancreatic Beta-Cell Protection Product
 Table 87. Pfizer Inc Revenue in Pancreatic Beta-Cell Protection Business (2020-2025) & (US$ Million)
 Table 88. Pfizer Inc Recent Development
 Table 89. BioLineRx Company Details
 Table 90. BioLineRx Business Overview
 Table 91. BioLineRx Pancreatic Beta-Cell Protection Product
 Table 92. BioLineRx Revenue in Pancreatic Beta-Cell Protection Business (2020-2025) & (US$ Million)
 Table 93. BioLineRx Recent Development
 Table 94. Genentech Company Details
 Table 95. Genentech Business Overview
 Table 96. Genentech Pancreatic Beta-Cell Protection Product
 Table 97. Genentech Revenue in Pancreatic Beta-Cell Protection Business (2020-2025) & (US$ Million)
 Table 98. Genentech Recent Development
 Table 99. Novo Nordisk Company Details
 Table 100. Novo Nordisk Business Overview
 Table 101. Novo Nordisk Pancreatic Beta-Cell Protection Product
 Table 102. Novo Nordisk Revenue in Pancreatic Beta-Cell Protection Business (2020-2025) & (US$ Million)
 Table 103. Novo Nordisk Recent Development
 Table 104. Sanofi Company Details
 Table 105. Sanofi Business Overview
 Table 106. Sanofi Pancreatic Beta-Cell Protection Product
 Table 107. Sanofi Revenue in Pancreatic Beta-Cell Protection Business (2020-2025) & (US$ Million)
 Table 108. Sanofi Recent Development
 Table 109. Osiris Therapeutics Company Details
 Table 110. Osiris Therapeutics Business Overview
 Table 111. Osiris Therapeutics Pancreatic Beta-Cell Protection Product
 Table 112. Osiris Therapeutics Revenue in Pancreatic Beta-Cell Protection Business (2020-2025) & (US$ Million)
 Table 113. Osiris Therapeutics Recent Development
 Table 114. Beta-O2 Technologies Ltd Company Details
 Table 115. Beta-O2 Technologies Ltd Business Overview
 Table 116. Beta-O2 Technologies Ltd Pancreatic Beta-Cell Protection Product
 Table 117. Beta-O2 Technologies Ltd Revenue in Pancreatic Beta-Cell Protection Business (2020-2025) & (US$ Million)
 Table 118. Beta-O2 Technologies Ltd Recent Development
 Table 119. Transition Therapeutics Company Details
 Table 120. Transition Therapeutics Business Overview
 Table 121. Transition Therapeutics Pancreatic Beta-Cell Protection Product
 Table 122. Transition Therapeutics Revenue in Pancreatic Beta-Cell Protection Business (2020-2025) & (US$ Million)
 Table 123. Transition Therapeutics Recent Development
 Table 124. Research Programs/Design for This Report
 Table 125. Key Data Information from Secondary Sources
 Table 126. Key Data Information from Primary Sources
 Table 127. Authors List of This Report


List of Figures
 Figure 1. Pancreatic Beta-Cell Protection Picture
 Figure 2. Global Pancreatic Beta-Cell Protection Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Pancreatic Beta-Cell Protection Market Share by Type: 2024 VS 2031
 Figure 4. Stem Cell Based Features
 Figure 5. Gene Therapies Features
 Figure 6. RNA Based Therapies Features
 Figure 7. Monoclonal Antibodies (MAbs) Features
 Figure 8. Phytotherapy Features
 Figure 9. Global Pancreatic Beta-Cell Protection Market Size by Application (2020-2031) & (US$ Million)
 Figure 10. Global Pancreatic Beta-Cell Protection Market Share by Application: 2024 VS 2031
 Figure 11. Hospital Case Studies
 Figure 12. Medical Research Laboratory Case Studies
 Figure 13. Others Case Studies
 Figure 14. Pancreatic Beta-Cell Protection Report Years Considered
 Figure 15. Global Pancreatic Beta-Cell Protection Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global Pancreatic Beta-Cell Protection Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Pancreatic Beta-Cell Protection Market Share by Region: 2024 VS 2031
 Figure 18. Global Pancreatic Beta-Cell Protection Market Share by Players in 2024
 Figure 19. Global Top Pancreatic Beta-Cell Protection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pancreatic Beta-Cell Protection as of 2024)
 Figure 20. The Top 10 and 5 Players Market Share by Pancreatic Beta-Cell Protection Revenue in 2024
 Figure 21. North America Pancreatic Beta-Cell Protection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America Pancreatic Beta-Cell Protection Market Share by Country (2020-2031)
 Figure 23. United States Pancreatic Beta-Cell Protection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada Pancreatic Beta-Cell Protection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Pancreatic Beta-Cell Protection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Pancreatic Beta-Cell Protection Market Share by Country (2020-2031)
 Figure 27. Germany Pancreatic Beta-Cell Protection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. France Pancreatic Beta-Cell Protection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. U.K. Pancreatic Beta-Cell Protection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Italy Pancreatic Beta-Cell Protection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Russia Pancreatic Beta-Cell Protection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Nordic Countries Pancreatic Beta-Cell Protection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Pancreatic Beta-Cell Protection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Pancreatic Beta-Cell Protection Market Share by Region (2020-2031)
 Figure 35. China Pancreatic Beta-Cell Protection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Japan Pancreatic Beta-Cell Protection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. South Korea Pancreatic Beta-Cell Protection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Southeast Asia Pancreatic Beta-Cell Protection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. India Pancreatic Beta-Cell Protection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Australia Pancreatic Beta-Cell Protection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Pancreatic Beta-Cell Protection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Pancreatic Beta-Cell Protection Market Share by Country (2020-2031)
 Figure 43. Mexico Pancreatic Beta-Cell Protection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Brazil Pancreatic Beta-Cell Protection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Pancreatic Beta-Cell Protection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Pancreatic Beta-Cell Protection Market Share by Country (2020-2031)
 Figure 47. Turkey Pancreatic Beta-Cell Protection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Pancreatic Beta-Cell Protection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. UAE Pancreatic Beta-Cell Protection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. ViaCyte Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2020-2025)
 Figure 51. PharmaCyte Biotech Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2020-2025)
 Figure 52. Boehringer Ingelheim Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2020-2025)
 Figure 53. GalaxoSmithKline Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2020-2025)
 Figure 54. Beta-Cell NV Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2020-2025)
 Figure 55. Novartis Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2020-2025)
 Figure 56. Janssen Research & Development Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2020-2025)
 Figure 57. Pfizer Inc Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2020-2025)
 Figure 58. BioLineRx Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2020-2025)
 Figure 59. Genentech Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2020-2025)
 Figure 60. Novo Nordisk Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2020-2025)
 Figure 61. Sanofi Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2020-2025)
 Figure 62. Osiris Therapeutics Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2020-2025)
 Figure 63. Beta-O2 Technologies Ltd Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2020-2025)
 Figure 64. Transition Therapeutics Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2020-2025)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global Insulinoma Market Research Report 2024
Artificial Pancreas Implant Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Insulin Biologics and Biosimilars Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pancreatic Cancer Diagnostic Market Insights Forecast to 2030
Global Artificial Pancreas Devices Systems Market Research Report 2025
Global Insulin Storage Devices Market Research Report 2024
Artificial Pancreas Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hormonal Therapy for Type 2 Diabetes Market Research Report 2024
Global Portable Insulin Cooler Cases Market Research Report 2024
Global Pancreatic Cancer Diagnostic Devices Market Insights Forecast to 2030
Global Recombinant Human Insulin Market Insights Forecast to 2030
Global Digital Insulin Cooler Market Research Report 2025
Diabetes Drug Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Islet Cell Autoantigen ELISA Test Kit Market Research Report 2024
Global Anti Islet cell antibody ICA ELISA Kit Market Research Report 2024
Global Closed Loop Artificial Pancreas System Market Research Report 2024
Global Insulin Drugs for Diabetes Market Research Report 2024
Insulin Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Insulin Management System Market Insights Forecast to 2030
Global β Interferon Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions